Cardiovascular

Microalbuminuria: Undervalued As A Risk Assessment Tool

June 18, 2009
Source: 19th European Meeting On Hypertension, Milan, June 12-16, 2009
Hermann Haller

Hermann Haller

Hermann Haller tells Peter Goodwin about the significant health risks—including for renal disease, myocardial infarction and stroke—which are going undetected across Europe because doctors are not testing their patients who have hypertension for microalbuminuria. He discusses the findings of a European Society of Hypertension survey revealing widespread ignorance among general practitioners, cardiologists and diabetologists.

Download this interview

Add podcast to iTunes

Similar Interviews

  • Audio Journal of Global Health Issues: Dementia Prevention By Mid-Life Risk Score Assessment?

    • Miia Kivipelto, Karolinska Institute, Stockholm REFERENCE: Lancet Neurology On Line: August 3rd, 2006 A 20 year study in Finland has

  • Audio Journal of Oncology – Prostate Cancer Special Edition 2005

    • Reporting from: - 2005 Multidisciplinary Prostate Cancer Symposium, February 17-19, Hyatt Grand Cypress, Orlando, Florida In this edition: Will they or won’t they

  • Methicillin-Resistant Staphylococcus Aureus: New Initiatives

    • Michele Pearson Michele Pearson, Centers for Disease Control and Prevention, Atlanta A community-wide approach is needed to combat MRSA according to a

    Post a comment